World revenue of collagen derivatives in 2023 was USD 8,694.1 million. The sales of collagen derivatives increased by year-on-year growth of 6.2% in 2024, and the world market would be USD 9,726.4 million in 2025. World sales would increase at CAGR of 6.2% for forecast period (2025 to 2035) and would be USD 17,750 million in 2035.
Collagen derivative market aims at growing uses of collagen derivative products across industries, i.e., food & beverages, cosmetic, and pharmaceutical. Collagen derivatives like hydrolysed collagen, gelatine, and collagen peptides are in demand on the basis of functional applications like skin elasticity, bone strength, and joint health.
Collagen's growing awareness of its health advantage to consumers, especially for joint, skincare, and anti-aging, are some of the industry drivers. Growing demands to natural, clean-label, and plant-based towards consumers also powered growing demand for collagen derivatives, especially for cosmetic and for nutraceutical business.
Collagen derivatives find widespread application in functional foods and beverages, dietary supplements, and cosmetics owing to their diverse health benefits. Collagen also enhances the moisturizing ability of skin, prevents wrinkle development, and enhances joint flexibility and hence is greatly sought after by consumers for their health and anti-aging.
Sustainability is also being heard in emerging market demand for collagen derivatives. While formerly obtained from fish, pigs, and bovines, the market has more and more been driven to seek increasingly towards sustainably sourced and plant-based collagen sources as a means of addressing ecologically conscious and vegan consumers. Clearly, there will be great power in the future with upcoming sustainable alternatives of collagen.
Below is the comparative half-yearly picture of CAGR volatility between the base year (2024) and the terminal year (2025) of the global market for collagen derivatives.
It displays the comparison, which is volatile performance, and provides revenue achievement trends, hence providing stakeholders with a perfect picture on the growth trend for the year. The first half year (H1) is between the months of January and June, and the second half year (H2) is between the months of July and December.
| Particular | Value CAGR |
|---|---|
| H1 (2024 to 2034) | 5.7% |
| H2 (2024 to 2034) | 5.9% |
| H1 (2025 to 2035) | 6.0% |
| H2 (2025 to 2035) | 6.2% |
The 2025 to 2035 period's H1 market will expand at a CAGR of 6.0%, and there is a marginal pick-up rate of 6.2% in the period's H2. The growth will gradually be picking up pace in the latter half of the decade as increasingly more consumers seek collagen derivatives, which have uses in beauty, personal care, wellness, and healthcare products. Though it was 30 BPS during the first half of the decade (H1), it will be healthier during the second half (H2) at 20 BPS.
This helical development with growing demand for collagen derivatives in diverse applications is setting the stage for the market to thrive in the forecast period. Overall, the market for collagen derivatives will experience excellent growth through diversification of applications and consumer trends. Ethics and sustainability will dictate long-term acceptance and growth of collagen products, however.
Global collagen derivatives market is comparatively concentrated with multinational firms, Chinese firms, and increasing presence of Chinese firms. Collagen derivative business on global scale is driven by increasing demands for collagen-containing materials in healthcare, food, cosmetics, and pharmacy. Local industries perform raw material procurement and processing the collagen into various forms of derivatives such as gelatin, hydrolyzed collagen, and collagen peptides.
Local players are predominant in the European, North American, and Asian-Pacific markets. North America's small and medium-sized enterprises are low-cost producers of collagen derivatives for the pharmaceutical, nutritional supplements, and cosmetic care industries.
The United States and Canada have a sophisticated collagen market with regional players dominating high-quality bovine and sea sources of collagen. These firms seek to acquire the latest extraction and purification technology to provide high-purity collagen derivatives to various end-use applications.
Europe has the largest market for collagen derivatives, with local industry players in France, Germany, and the Netherlands. These firms focus on sustainable sourcing, regulatory compliance, and innovation from collagen-derived ingredients. Collagen derivatives are required in the European market due to an exigency of a boost in health and beauty benefits and drive local players to invest in research and development to increase the functionality of the products.
India, Japan, and South Korea in Asia-Pacific have local players as market leaders in the collagen derivatives industry. There is a developing Indian collagen market with pharmaceuticals and nutraceuticals taking center stage. Japan and South Korea possess developed collagen markets with local players competing in peptides and hydrolyzed collagen for cosmetics and anti-aging.
Chinese firms have been capturing market share in the worldwide collagen derivatives market by exporting low-cost products and expanding processing capacities. China has emerged as a significant source of collagen-based ingredients both in China and around the world. Chinese firms are cost-reduction and volume-driven output and have been leading drivers of global value chains.
Increasing Demand for Collagen in Personalized Nutrition
Shift: Personalized nutrition food is being ordered by consumers seeking nutrition according to lifestyle, age, and individual health needs. There is increasing demand for targeted collagen supplements for joint health, skin elasticity, gut health, and muscle recovery, particularly in Europe and North America where the popularity of nutraceuticals and functional food is on the rise.
Strategic Response: Based on individual needs, companies are designing collagen products with tailored formulations. Persona Nutrition launched a line of personalized collagen supplements in which the customer can choose marine, bovine, or vegan blends based on what health benefit is desired.
Ancient Nutrition launched multi-collagen protein powders with probiotics and adaptogens added for gut support and stress reduction. In the meantime, Nutrafol mixed collagen peptides with hair growth and beauty supplements, which led to consumer demand for full-beauty and wellness.
Increasing Application of Collagen Derivatives in Plant and Hybrid Alternatives
Shift: With increasing numbers of individuals adopting vegan and flexitarian consumption, consumers are looking for plant-based alternatives to conventional animal-derived collagen. Although collagen is animal-derived, companies are developing collagen-stimulating plant extracts that trigger natural collagen synthesis using ingredients such as amino acids, vitamin C, and silica.
Strategic Response: In order to reach this market, brands are developing vegan collagen stimulators. Moon Juice released a vegan-friendly collagen support supplement with hyaluronic acid, bamboo extract, and tremella mushroom that gained 16% in the market growth of vegan-friendly collagen alternatives.
Ritual developed a collagen-stimulating supplement with pea protein and ceramides directed at green-conscious consumers. The Beauty Chef developed a bio-fermented collagen booster stimulating natural collagen generation targeted at clean-label and organic beauty consumers.
Collagen Growth in Gut Wellness and Digestive Health
Shift: Collagen's application in gut lining healing, inflammation control, and digestive well-being is gaining traction, especially among consumers who have leaky gut syndrome, IBS, and gluten intolerance. With gut wellness becoming the focus as the central pillar of overall wellness, collagen-fortified probiotics, bone broths, and gut-friendly supplements are on the rise.
Strategic Response: Brands are pairing collagen with gut-friendly nutrients to support digestive health. Vital Proteins introduced a collagen-infused bone broth with the added presence of prebiotics, whose sales increased 23% among consumers with gastrointestinal health concerns.
Garden of Life introduced a probiotic-enriched collagen powder, combining bovine collagen with gut-soothing bacteria. Ancient Nutrition introduced a multi-collagen product with ginger and turmeric, targeting whole health consumers seeking anti-inflammatory benefits.
Other Meat and Dairy Alternatives Utilize Collagen
Shift: Growing demand for functional and protein-concentrated dairy/meat alternatives is propelling collagen to be incorporated in protein-based milk, yogurt, and meat alternative food. The trend is gaining momentum in North America and Europe, with functional foods shaping the next stage of alternative proteins.
Strategic Response: Companies are introducing collagen-fortified dairy and meat substitutes. Perfect Day created a collagen-fortified dairy-free protein beverage that boosted demand by 14% among lactose-intolerant consumers. Beyond Meat experimented with collagen-fortified plant-based meat burgers with enhanced texture and protein functionality. Maeil Dairy, in South Korea, introduced collagen-fortified oat milk, riding the wave of growing demand for fortified dairy products.
Collagen-Infused Beverages and Functional Drinks Innovations
Shift: Collagen ready-to-drink (RTD) drinks are gaining momentum as healthy drinks on-the-go, especially in North America and Asia. People find it simpler to drink collagen-fortified coffees, teas, and fizzy drinks compared to the traditional powders and capsules.
Strategic Response: To meet this demand, firms are launching collagen-fortified functional drinks. Vital Proteins & Starbucks partnered to co-introduce a collagen-fortified cold brew, which created a 19% increase in RTD collagen drink sales.
Shiseido introduced a collagen-fortified sparkling water in Japan targeting young consumers seeking beauty-from-within products. REBBL, however, introduced a collagen-fortified adaptogenic elixir, with marine collagen, ashwagandha, and reishi mushrooms, riding stress-reduction and wellness trends.
Collagen Demand Boom for Bone and Joint Health Supplements
Shift: Demographic aging and increasing consumer awareness of bone mineral loss, osteoarthritis, and joint pain are compelling consumers to buy more collagen supplements to aid cartilage regrowth and bone health. Mature consumers, athletes, and arthritis consumers lead demand, mainly, and are propelling medical nutrition and orthopedic wellness product expansion.
Strategic Response: For fulfilling this demand, business organizations are producing collagen products specifically for joint and bone care. BioCell Collagen introduced a hydrolyzed type II collagen dietary supplement that was clinically proven to reduce joint tenderness and stiffness, and this led to a 17% sales increase in the aging population market.
Move Free (Schiff Vitamins) introduced combinations of collagen-chondroitin-glucosamine, making them more desirable for arthritis patients as well as sportmen. At the same time, Swisse Wellness brought to market a calcium- and vitamin D-fortified marine collagen supplement for European and Australian consumers who are bone health-conscious.
Expanded Collagen Application in Clinical and Wound Treatments
Shift: Applications of collagen in tissue engineering, wound healing, and post-surgical recovery are on the rise in pharmaceutical and medical sectors. With biomaterials from collagen finding growing applications for medical use in skin grafting, burn treatment, and surgical dressings, biopharmaceutical and biotech companies are investing in medical devices with embedded collagen.
Strategic Response: Medical and biotech companies are launching new collagen therapies to capitalize on this trend. Integra LifeSciences developed collagen dressings for wound, which promoted skin regeneration in surgical or burnt patients.
DSM Biomedical developed collagen hydrogel that promoted tissue engineering and improved the efficiency of healing in a wound by 27% via clinical trials. For its part, Smith & Nephew developed its bandage line featuring collagen and added greater integration in North American and European hospitals and surgery centers.
The following table shows the estimated growth rates of the top five territories expected to exhibit high consumption of collagen derivatives through 2035.
| Countries | CAGR, 2025 to 2035 |
|---|---|
| USA | 6.5% |
| Germany | 8.0% |
| China | 4.3% |
| Japan | 5.7% |
| India | 6.1% |
However, the USA collagen derivatives market is driven by growing consumer inclination towards functional food, beauty supplements and joint health preparations. However, they are also majorly utilized in skin health supplements, sports nutrition products, and even anti-ager treatments.
Moreover, the increasing utilization of collagen derivatives with high purity in pharmaceutical and cosmetic sectors due to innovation in collagen extraction technologies is driving the market growth.
Germany's collagen derivatives market is experiencing steady growth on the back of EU regulations that aliment clean-label, non-GMO, and sustainable ingredients. There is an increasing demand for alternatives to marine-based and plant-derived collagen in nutraceuticals, cosmeceuticals and functional beverages.
As growing numbers of consumers opt for vegan and vegetarian diets, manufacturers are focusing on fermentation-derived collagen and plant-based collagen boosters.
Rising demand for nourishing collagen supplements, functional beverages, and regenerative medicine applications is rapidly driving the growth of China’s collagen derivatives market. Consumer awareness of collagen’s part in skin elasticity, bone density and joint health drives the market.
Demand for collagen biomaterials for wound healing, tissue engineering, and medical implants is also being invigorated by China’s robust pharmaceutical and biomedical research industry.
Japan’s collagen derivatives market is fueled by the nation’s inclination for pure, marine-based collagen for beauty, anti-aging, and health-related applications. In supplements or functional foods or skincare formulationsJapanese consumers are more likely to choose products with an inclusion of hydrolyzed marine collagen peptides.
Moreover, Japan is making progress in collagen fermentation and microencapsulation, which enhance the absorption and bioavailability of collagen in cosmeceutical products.
Demand for a strong collagen derivatives market in India has been driven by mounting awareness of functional nutrition, greater emphasis on sports nutrition and rising levels of disposable income. The growing demand for affordable collagen-based dietary supplements and Ayurvedic collagen formulations are anticipated to boost collagen supplements demand.
The demand for collagen-infused functional foods, collagen and collagen-infused products has increased owing to support from the government for nutraceuticals, and the rising trend of e-commerce.
| Segment | Value Share (2025) |
|---|---|
| Collagen Peptides & Hydrolyzed Collagen (By Type) | 63.5% |
In terms of type, the hydrolyzed collagen and collagen peptides segment is expected to dominate the market for collagen derivatives till 2025, holding a 63.5% market share. The segment enjoys the highest demand due to its superior bioavailability, easy digestion and versatility in several functional food & health applications.
Collagen peptides are a central ingredient in anti-aging skincare and beauty supplements, protein powders and hence stand as a principal ingredient in the flourishing nutraceutical and cosmeceutical sectors.
The producers are expanding their line of marine collagen and hydrolyzed bovine collagen products in light of increasing consumer interest in quality and sustainably produced collagen. Increased popularity of fortified collagen blends commonly with vitamins, hyaluronic acid, and amino acids for enhanced joint function and moisturizing of skin, post-exercise recovery, etc., is also noted.
As clean-label supplements and personalized nutrition become more mainstream, the market for collagen peptides is ready to experience record-breaking growth, breakthrough innovations, and diversification, further solidifying its place in the global wellness and beauty industry.
| Segment | Value Share (2025) |
|---|---|
| Gelatin & Collagen-Based Biomaterials (By Type) | 36.5% |
Growing use of gelatin and collagen-based biomaterials in pharmaceuticals, regenerative medicine, and functional food manufacture is expected to hold a 36.5% market share in the year 2025. Gummy supplements, soft gel capsules, and enriched dairy products depend on gelatin for their structure, while collagen-based biomaterials have uses in surgical implants, wound dressings, and tissue engineering due to their biocompatibility and regenerative nature.
To advance even more into the future of biomedical research, firms are seeking functional bioengineered collagen scaffolds, injectable formulations of collagen, and drug delivery systems based on collagen to aid in tissue repair and regenerative treatments.
The plant and hybrid protein markets also are having a greater interest in collagen-enriched meat substations, as well as other emerging alternative protein sources that offer opportunities for product innovation in functional food and nutraceutical markets.
Consumer understanding of collagen's health advantages to skin, joint and bone well-being is increasing, and the market will continue to expand. Increasing focus on sustainable and high purity collagen extraction technologies will drive innovation, advancements and market penetration in numerous industries.
Leading Players in the Market are Embracing Sustainable Sourcing & Bioengineering Approaches for Collagen Derivatives Expansion Marine-based collagen, enzymatically hydrolyzed peptides and vegan-friendly collagen alternatives are being bet on by companies.
Major players in the industry, including Rousselot, Gelita, Nitta Gelatin, Collagen Solutions, and PB Leiner concentration at collagen hydrolysis, medical grade collagen, and beauty-driven formulations. With demand for anti-aging supplements and regenerative medicine solutions increasing, many companies are investing in adding to their operations in the Asia-Pacific and North American markets.
The main approaches comprise of collaborations with biotech companies, participation in high-purity collagen processing and the creation of synthetic collagen analogues. In addition, manufacturers are focusing on eco-friendly collagen extraction processes and new fermentation techniques.
For instance:
The market includes products derived from various sources, including Bovine, Marine, and Porcine, catering to different industry requirements.
These products are available in two primary forms, Liquid and Powder, offering versatility for various applications.
They are widely used across multiple industries, including Food and Beverage, Pharmaceutical, Cosmetics, and Nutraceuticals, highlighting their broad utility.
The market is segmented as North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Central Asia, Russia and Belarus, Balkan & Baltic Countries, Middle East and Africa.
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Volume (MT) Forecast by Region, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 4: Global Market Volume (MT) Forecast by Source, 2018 to 2033
Table 5: Global Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 6: Global Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 7: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 8: Global Market Volume (MT) Forecast by Application, 2018 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: North America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 11: North America Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 12: North America Market Volume (MT) Forecast by Source, 2018 to 2033
Table 13: North America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 14: North America Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 15: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 16: North America Market Volume (MT) Forecast by Application, 2018 to 2033
Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Latin America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 19: Latin America Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 20: Latin America Market Volume (MT) Forecast by Source, 2018 to 2033
Table 21: Latin America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 22: Latin America Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 23: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 24: Latin America Market Volume (MT) Forecast by Application, 2018 to 2033
Table 25: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: Europe Market Volume (MT) Forecast by Country, 2018 to 2033
Table 27: Europe Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 28: Europe Market Volume (MT) Forecast by Source, 2018 to 2033
Table 29: Europe Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 30: Europe Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 31: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 32: Europe Market Volume (MT) Forecast by Application, 2018 to 2033
Table 33: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 34: East Asia Market Volume (MT) Forecast by Country, 2018 to 2033
Table 35: East Asia Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 36: East Asia Market Volume (MT) Forecast by Source, 2018 to 2033
Table 37: East Asia Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 38: East Asia Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 39: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 40: East Asia Market Volume (MT) Forecast by Application, 2018 to 2033
Table 41: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 42: South Asia Market Volume (MT) Forecast by Country, 2018 to 2033
Table 43: South Asia Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 44: South Asia Market Volume (MT) Forecast by Source, 2018 to 2033
Table 45: South Asia Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 46: South Asia Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 47: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 48: South Asia Market Volume (MT) Forecast by Application, 2018 to 2033
Table 49: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 50: Oceania Market Volume (MT) Forecast by Country, 2018 to 2033
Table 51: Oceania Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 52: Oceania Market Volume (MT) Forecast by Source, 2018 to 2033
Table 53: Oceania Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 54: Oceania Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 55: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 56: Oceania Market Volume (MT) Forecast by Application, 2018 to 2033
Table 57: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 58: MEA Market Volume (MT) Forecast by Country, 2018 to 2033
Table 59: MEA Market Value (US$ Million) Forecast by Source, 2018 to 2033
Table 60: MEA Market Volume (MT) Forecast by Source, 2018 to 2033
Table 61: MEA Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 62: MEA Market Volume (MT) Forecast by Dosage Form, 2018 to 2033
Table 63: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 64: MEA Market Volume (MT) Forecast by Application, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Source, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Volume (MT) Analysis by Region, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 10: Global Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 13: Global Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 14: Global Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 17: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 18: Global Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 21: Global Market Attractiveness by Source, 2023 to 2033
Figure 22: Global Market Attractiveness by Dosage Form, 2023 to 2033
Figure 23: Global Market Attractiveness by Application, 2023 to 2033
Figure 24: Global Market Attractiveness by Region, 2023 to 2033
Figure 25: North America Market Value (US$ Million) by Source, 2023 to 2033
Figure 26: North America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 27: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 28: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 29: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 30: North America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 33: North America Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 34: North America Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 37: North America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 38: North America Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 39: North America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 40: North America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 41: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 42: North America Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 43: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 44: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 45: North America Market Attractiveness by Source, 2023 to 2033
Figure 46: North America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 47: North America Market Attractiveness by Application, 2023 to 2033
Figure 48: North America Market Attractiveness by Country, 2023 to 2033
Figure 49: Latin America Market Value (US$ Million) by Source, 2023 to 2033
Figure 50: Latin America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 52: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 54: Latin America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 57: Latin America Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 58: Latin America Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 61: Latin America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 62: Latin America Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 65: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 66: Latin America Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 69: Latin America Market Attractiveness by Source, 2023 to 2033
Figure 70: Latin America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 73: Europe Market Value (US$ Million) by Source, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 75: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 76: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 77: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 78: Europe Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 82: Europe Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 83: Europe Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 84: Europe Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 85: Europe Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 86: Europe Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 87: Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 88: Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 89: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 90: Europe Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 93: Europe Market Attractiveness by Source, 2023 to 2033
Figure 94: Europe Market Attractiveness by Dosage Form, 2023 to 2033
Figure 95: Europe Market Attractiveness by Application, 2023 to 2033
Figure 96: Europe Market Attractiveness by Country, 2023 to 2033
Figure 97: East Asia Market Value (US$ Million) by Source, 2023 to 2033
Figure 98: East Asia Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 99: East Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 100: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 101: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 102: East Asia Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 103: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 104: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 105: East Asia Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 106: East Asia Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 107: East Asia Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 109: East Asia Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 110: East Asia Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 111: East Asia Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 112: East Asia Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 113: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 114: East Asia Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 115: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 117: East Asia Market Attractiveness by Source, 2023 to 2033
Figure 118: East Asia Market Attractiveness by Dosage Form, 2023 to 2033
Figure 119: East Asia Market Attractiveness by Application, 2023 to 2033
Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 121: South Asia Market Value (US$ Million) by Source, 2023 to 2033
Figure 122: South Asia Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 123: South Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 124: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 125: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: South Asia Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 127: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 128: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 129: South Asia Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 130: South Asia Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 131: South Asia Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 132: South Asia Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 133: South Asia Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 134: South Asia Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 135: South Asia Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 136: South Asia Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 137: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 138: South Asia Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 139: South Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 140: South Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 141: South Asia Market Attractiveness by Source, 2023 to 2033
Figure 142: South Asia Market Attractiveness by Dosage Form, 2023 to 2033
Figure 143: South Asia Market Attractiveness by Application, 2023 to 2033
Figure 144: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 145: Oceania Market Value (US$ Million) by Source, 2023 to 2033
Figure 146: Oceania Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 147: Oceania Market Value (US$ Million) by Application, 2023 to 2033
Figure 148: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 149: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 150: Oceania Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 151: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 152: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 153: Oceania Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 154: Oceania Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 155: Oceania Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 156: Oceania Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 157: Oceania Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 158: Oceania Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 159: Oceania Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 160: Oceania Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 161: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 162: Oceania Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 165: Oceania Market Attractiveness by Source, 2023 to 2033
Figure 166: Oceania Market Attractiveness by Dosage Form, 2023 to 2033
Figure 167: Oceania Market Attractiveness by Application, 2023 to 2033
Figure 168: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 169: MEA Market Value (US$ Million) by Source, 2023 to 2033
Figure 170: MEA Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 171: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 172: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 173: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 174: MEA Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 175: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 176: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 177: MEA Market Value (US$ Million) Analysis by Source, 2018 to 2033
Figure 178: MEA Market Volume (MT) Analysis by Source, 2018 to 2033
Figure 179: MEA Market Value Share (%) and BPS Analysis by Source, 2023 to 2033
Figure 180: MEA Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033
Figure 181: MEA Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 182: MEA Market Volume (MT) Analysis by Dosage Form, 2018 to 2033
Figure 183: MEA Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 184: MEA Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 185: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 186: MEA Market Volume (MT) Analysis by Application, 2018 to 2033
Figure 187: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 188: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 189: MEA Market Attractiveness by Source, 2023 to 2033
Figure 190: MEA Market Attractiveness by Dosage Form, 2023 to 2033
Figure 191: MEA Market Attractiveness by Application, 2023 to 2033
Figure 192: MEA Market Attractiveness by Country, 2023 to 2033
The global collagen derivatives industry is projected to reach USD 9,726.4 million in 2025.
Key players include Rousselot; PB Collagen; Nippon Collagen; Gelita; Weishardt; PB Gelatin; Nitta Gelatin; Darling Ingredients.
Asia-Pacific is expected to dominate due to high demand for beauty and health supplements, increasing pharmaceutical applications, and growing collagen-infused food trends.
The industry is forecasted to grow at a CAGR of 6.2% from 2025 to 2035.
Key drivers include rising demand for anti-aging and beauty-enhancing supplements, increasing use in regenerative medicine, and advancements in sustainable collagen extraction technologies.
Explore Similar Insights
Collagen Derivatives Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
